Researchers at Dana-Farber Cancer Institute have developed a blood test that could transform the diagnosis and monitoring of multiple myeloma (MM) and its precursor conditions. The new method, known ...
MPNs involve overproduction of blood cells, while MDS results in poorly formed cells, affecting blood cell function and counts. Diagnosis requires blood tests, bone marrow biopsy, and genetic testing ...
Even though I have a degree in biology, I knew little about cancer – until life gave me a crash course. In 2019, while working on my master’s degree in Huntsville, I developed severe leg pain. At ...
Researchers at Dana-Farber Cancer Institute have developed a blood test that could transform the diagnosis and monitoring of multiple myeloma (MM) and its precursor conditions. The new method, known ...
A combination of genetic tests for a "very complex" blood cancer could accurately predict if the disease is likely to return ...
What if a blood test could reveal the pace of our aging – and the diseases that may lie ahead? The labs of Profs. Liran Shlush and Amos Tanay at the Weizmann Institute of Science have been conducting ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback